|
US4444879A
(en)
|
1981-01-29 |
1984-04-24 |
Science Research Center, Inc. |
Immunoassay with article having support film and immunological counterpart of analyte
|
|
US4517289A
(en)
|
1982-08-18 |
1985-05-14 |
Brigham And Women's Hospital |
Monoclonal antibodies for human tissue cross-matching
|
|
US4816567A
(en)
|
1983-04-08 |
1989-03-28 |
Genentech, Inc. |
Recombinant immunoglobin preparations
|
|
US4921789A
(en)
|
1988-04-20 |
1990-05-01 |
New England Deaconess Hospital Corporation |
Marker for colorectal carcinoma and methods of detecting the same
|
|
US5344760A
(en)
|
1991-06-03 |
1994-09-06 |
Ciba Corning Diagnostics Corp. |
Method of cancer detection
|
|
US5786158A
(en)
|
1992-04-30 |
1998-07-28 |
Yale University |
Therapeutic and diagnostic methods and compositions based on notch proteins and nucleic acids
|
|
US5790761A
(en)
|
1992-12-11 |
1998-08-04 |
Heseltine; Gary L. |
Method and apparatus for the diagnosis of colorectal cancer
|
|
AU6350894A
(en)
|
1993-03-05 |
1994-09-26 |
Clifford W. Schweinfest |
Colon mucosa gene having down-regulated expression in colon adenomas and adenocarcinomas
|
|
US7229770B1
(en)
|
1998-10-01 |
2007-06-12 |
The Regents Of The University Of California |
YKL-40 as a marker and prognostic indicator for cancers
|
|
DK85193D0
(da)
|
1993-07-16 |
1993-07-16 |
Cancerforskningsfondet Af 1989 |
Suppression of inhibitors
|
|
US6316208B1
(en)
|
1994-01-07 |
2001-11-13 |
Memorial Sloan-Kettering Cancer Center |
Methods for determining isolated p27 protein levels and uses thereof
|
|
JP2002515965A
(ja)
|
1995-08-18 |
2002-05-28 |
ダブリュー． ランドリ，ドナルド |
抗体触媒反応の調節による有機化合物の検出
|
|
US5800347A
(en)
|
1995-11-03 |
1998-09-01 |
The General Hospital Corporation |
ROC method for early detection of disease
|
|
NO954667D0
(no)
|
1995-11-17 |
1995-11-17 |
Dagfinn Oegreid |
Fremgangsmåte til deteksjon av Ki-ras mutasjoner
|
|
US5983211A
(en)
|
1996-01-24 |
1999-11-09 |
Heseltine; Gary L. |
Method and apparatus for the diagnosis of colorectal cancer
|
|
US6242212B1
(en)
|
1996-02-09 |
2001-06-05 |
Thomas Jefferson University |
Fragile histidine triad (FHIT) nucleic acids and methods of producing FHIT proteins
|
|
GB9810040D0
(en)
|
1998-05-11 |
1998-07-08 |
Univ Nottingham |
Blood borne tumour markers
|
|
WO1999064450A2
(en)
|
1998-06-12 |
1999-12-16 |
Chiron Corporation |
Cif130 inhibits cell cycle progression
|
|
GB9827228D0
(en)
|
1998-12-10 |
1999-02-03 |
Univ Nottingham |
Cancer detection method and reagents
|
|
CA2372667A1
(en)
|
1999-01-10 |
2000-11-23 |
Steven Laken |
Methods of detecting colorectal disease by conduction an assay to detect a mutation in a bat-26 locus
|
|
US7153700B1
(en)
|
1999-03-26 |
2006-12-26 |
Dana-Farber Cancer Institute, Inc. |
Methods and compositions for diagnosing and predicting the behavior of cancer
|
|
NZ515311A
(en)
|
1999-04-09 |
2002-11-26 |
Rigshospitalet |
Mass screening and highly specific early identification of colorectal or metastatic breast cancer by measuring TIMP-1 tissue inhibitor
|
|
US20010041365A1
(en)
|
2000-01-10 |
2001-11-15 |
Michael Laposata |
Methods for monitoring alcohol consumption
|
|
US6322986B1
(en)
|
2000-01-18 |
2001-11-27 |
Albany Medical College |
Method for colorectal cancer prognosis and treatment selection
|
|
US7301016B2
(en)
|
2000-03-07 |
2007-11-27 |
Millennium Pharmaceuticals, Inc. |
Human transferase family members and uses thereof
|
|
US7577683B2
(en)
|
2000-06-08 |
2009-08-18 |
Ingenuity Systems, Inc. |
Methods for the construction and maintenance of a knowledge representation system
|
|
US6531283B1
(en)
|
2000-06-20 |
2003-03-11 |
Molecular Staging, Inc. |
Protein expression profiling
|
|
AU2001280639A1
(en)
|
2000-07-18 |
2002-01-30 |
Millennium Pharmaceuticals, Inc. |
13237,18480,2245 or 16228 human protein kinase molecules and uses therefor
|
|
US6706506B2
(en)
|
2000-07-24 |
2004-03-16 |
Cornell Research Foundation, Inc. |
Detection of epithelial cell cancers and precancerous conditions
|
|
EP1364012A2
(en)
|
2000-11-08 |
2003-11-26 |
Millennium Pharmaceuticals, Inc. |
38650, 28472, 5495, 65507, 81588 and 14354 methods and compositions of human proteins and uses thereof
|
|
US7312086B2
(en)
|
2000-12-07 |
2007-12-25 |
Bristol-Myers Squibb Company |
Methods of diagnosing colon adenocarcinoma using the human g-protein coupled receptor hgprbmy23
|
|
JP2005518779A
(ja)
|
2001-03-23 |
2005-06-30 |
イェダ リサーチ アンド デベロップメント カンパニー リミテッド |
ガンを発症する危険性を明らかにするための方法およびキット、ガン治療の有効性および投与量を評価するための方法およびキット、ならびにｄｎａ修復酵素の活性とガンとを相関させるための方法およびキット
|
|
WO2002092854A2
(en)
|
2001-05-16 |
2002-11-21 |
Novartis Ag |
Genes expressed in breast cancer as prognostic and therapeutic targets
|
|
US7031846B2
(en)
|
2001-08-16 |
2006-04-18 |
Affymetrix, Inc. |
Method, system, and computer software for the presentation and storage of analysis results
|
|
ATE504594T1
(de)
|
2001-09-07 |
2011-04-15 |
Univ Johns Hopkins Med |
Sezernierte und zelloberflächengene, die in gutartigen und bösartigen kolorektaltumoren exprimiert werden
|
|
US20040018973A1
(en)
|
2002-01-25 |
2004-01-29 |
University Of Pittsburgh |
Nuclear matrix protein alterations associated with colon cancer and colon metastasis to the liver, and uses thereof
|
|
US20030186248A1
(en)
|
2002-03-29 |
2003-10-02 |
Erlander Mark G. |
Interpreting cytological specimens via molecular histological signatures
|
|
EP1367395A1
(de)
|
2002-05-02 |
2003-12-03 |
B.R.A.H.M.S Aktiengesellschaft |
Diagnose von Neoplasmen mit Hilfe von anti-Gangliosid-Antikörpern
|
|
WO2003097872A2
(en)
|
2002-05-21 |
2003-11-27 |
Mtm Laboratories Ag |
G - protein coupled receptor marker molecules associated with colorectal lesions
|
|
US20050153382A1
(en)
|
2002-06-06 |
2005-07-14 |
Chengdu Kuachang Science And Technology Co., Ltd. |
Biochip kit comprising biochip based on antigen-antibody reactions, and its usage
|
|
US7425700B2
(en)
|
2003-05-22 |
2008-09-16 |
Stults John T |
Systems and methods for discovery and analysis of markers
|
|
AU2004258085B2
(en)
|
2003-07-10 |
2010-05-27 |
Genomic Health, Inc. |
Expression profile algorithm and test for cancer prognosis
|
|
DE102004037860A1
(de)
|
2004-08-04 |
2006-03-16 |
Friedrich-Alexander-Universität Erlangen-Nürnberg |
Turmormarker zur Diagnose von Karzinomen und/oder davon abstammender Metastasen
|
|
WO2006015616A1
(en)
|
2004-08-13 |
2006-02-16 |
Indivumed Gmbh |
Use of transthyretin as a biomarker for colorectal adenoma and/or carcinoma; method for detection and test system
|
|
US20060105419A1
(en)
|
2004-08-16 |
2006-05-18 |
Biosite, Inc. |
Use of a glutathione peroxidase 1 as a marker in cardiovascular conditions
|
|
CA2584723A1
(en)
|
2004-10-22 |
2006-05-04 |
Redpath Integrated Pathology, Inc. |
Enhanced amplifiability of minute fixative-treated tissue samples, minute stained cytology samples, and other minute sources of dna
|
|
US9109256B2
(en)
|
2004-10-27 |
2015-08-18 |
Esoterix Genetic Laboratories, Llc |
Method for monitoring disease progression or recurrence
|
|
WO2006094149A2
(en)
|
2005-03-01 |
2006-09-08 |
Exact Sciences Corporation |
Methods and compositions for detecting adenoma
|
|
WO2006102526A2
(en)
|
2005-03-22 |
2006-09-28 |
Government Of The Usa, As Represented By The Secretary, Dept. Of Health And Human Services |
Identification of biomarkers by serum protein profiling
|
|
WO2007016367A2
(en)
|
2005-07-29 |
2007-02-08 |
Bayer Healthcare Llc |
Neoplastic disease-related methods, kits, systems and databases
|
|
SG165370A1
(en)
|
2005-09-12 |
2010-10-28 |
Phenomenome Discoveries Inc |
Method for the diagnosis of colorectal cancer and ovarian cancer by the measurement of vitamin e-related metabolites
|
|
US20080255764A1
(en)
|
2005-09-12 |
2008-10-16 |
Phenomenome Discoveries Inc. |
Methods for the Diagnosis of Colorectal Cancer and Ovarian Cancer by the Measurement of Vitamin E-Related Metabolites
|
|
ES2394925T3
(es)
|
2005-09-27 |
2013-02-06 |
University Of Saskatchewan |
Uso de N-miristoiltransferasa en tejido no tumoral para el diagnóstico de cáncer
|
|
EP1946118A4
(en)
|
2005-11-10 |
2009-01-21 |
Aurelium Biopharma Inc |
TISSUE DIAGNOSIS OF BREAST CANCER
|
|
GB0524190D0
(en)
|
2005-11-28 |
2006-01-04 |
Helse Stavanger Hf |
Method
|
|
ES2277785B1
(es)
|
2005-12-21 |
2008-06-16 |
Oryzon Genomics, S.A. |
Metodo de analisis de expresion diferencial en cancer colorectal.
|
|
US20090035801A1
(en)
|
2005-12-27 |
2009-02-05 |
Power3 Medical Products, Inc. |
Twelve (12) protein biomarkers for diagnosis and early detection of breast cancer
|
|
NZ593226A
(en)
|
2006-01-11 |
2012-10-26 |
Genomic Health Inc |
Gene expression markers (efnb2) for colorectal cancer prognosis
|
|
WO2007090125A2
(en)
|
2006-01-30 |
2007-08-09 |
Introgen Therapeutics, Inc. |
Prognostic factors for anti-hyperproliferative disease gene therapy
|
|
WO2007127002A2
(en)
|
2006-03-31 |
2007-11-08 |
Cell Signaling Technology, Inc. |
Protein markers of responsiveness to type iii receptor tyrosine kinase inhibitors
|
|
WO2007149456A2
(en)
|
2006-06-19 |
2007-12-27 |
Vanderbilt University |
Methods and compositions for diagnostic and therapeutic targeting of cox-2
|
|
US7811778B2
(en)
|
2006-09-06 |
2010-10-12 |
Vanderbilt University |
Methods of screening for gastrointestinal cancer
|
|
ES2543015T3
(es)
|
2006-12-08 |
2015-08-13 |
The Johns Hopkins University |
Estrategia de quimioprevención del cáncer basada en la pérdida de la impronta de IGF2
|
|
ATE535805T1
(de)
|
2007-01-26 |
2011-12-15 |
Univ Louisville Res Found |
Verfahren zur erkennung von autoantikörpern zur diagnostizierung und charakterisierung von erkrankungen
|
|
WO2008116178A2
(en)
|
2007-03-21 |
2008-09-25 |
Vanderbilt University |
Systems and methods for diagnosis and prognosis of colorectal cancer
|
|
CN101971033A
(zh)
|
2007-06-04 |
2011-02-09 |
戴诺普雷克斯公司 |
用于结直肠癌的生物标志物组合
|
|
DE102007034993A1
(de)
|
2007-07-26 |
2009-01-29 |
Hanna Diehl |
Lösliches Cadherin 17 für die Diagnose und Risikostratifizierung von Darmtumor oder Darmkrebs
|
|
US8883440B2
(en)
|
2007-07-26 |
2014-11-11 |
Nancy M. Lee |
Method to predict or diagnose a gastrointestinal disorder or disease
|
|
US8426140B2
(en)
|
2007-09-28 |
2013-04-23 |
Royal College Of Surgeons In Ireland |
Method of assessing colorectal cancer status in an individual
|
|
ATE521894T1
(de)
|
2007-11-20 |
2011-09-15 |
Hoffmann La Roche |
Verfahren zur beurteilung von kolorektalem krebs anhand einer stuhlprobe durch verwendung einer marker-kombination aus calprotectin und einem hämoglobin/haptoglobin-komplex
|
|
KR101058753B1
(ko)
|
2007-11-22 |
2011-08-24 |
한국생명공학연구원 |
대장암 마커로서의 ｅｓｍ－１ 유전자 및 이를 이용한대장암의 진단 및 치료에의 용도
|
|
CN101896817A
(zh)
*
|
2007-12-10 |
2010-11-24 |
霍夫曼-拉罗奇有限公司 |
用于结直肠癌的标记物组
|
|
CN101896818B
(zh)
|
2007-12-10 |
2016-01-20 |
霍夫曼-拉罗奇有限公司 |
作为癌症的标记物的Seprase
|
|
CA2715348A1
(en)
|
2008-02-08 |
2009-08-13 |
Poniard Pharmaceuticals, Inc. |
Use of picoplatin and bevacizumab to treat colorectal cancer
|
|
JP2011511635A
(ja)
|
2008-02-11 |
2011-04-14 |
ハダシット メディカル リサーチ サービシーズ アンド ディベロップメント リミテッド |
癌標識としての結腸癌関連転写因子１（ｃｃａｔ−１）
|
|
JPWO2009107170A1
(ja)
|
2008-02-29 |
2011-06-30 |
学校法人日本大学 |
抗ｃｒｐ抗体及びその利用
|
|
US20110245087A1
(en)
|
2008-03-18 |
2011-10-06 |
Gunter Weiss |
Method for optimizing and validating an assay for determining the presence or absence of a medical condition
|
|
US20110104256A1
(en)
|
2008-03-25 |
2011-05-05 |
Yaolin Wang |
Methods for treating or preventing colorectal cancer
|
|
WO2009125303A2
(en)
|
2008-04-10 |
2009-10-15 |
Genenews Corporation |
Method and apparatus for determining a probability of colorectal cancer in a subject
|
|
CA2724433A1
(en)
|
2008-05-14 |
2009-11-19 |
Eth Zuerich |
Method for biomarker and drug-target discovery for prostate cancer diagnosis and treatment as well as biomarker assays determined therewith
|
|
ES2506116T3
(es)
|
2008-05-23 |
2014-10-13 |
Biocartis Nv |
Nuevo biomarcador para diagnóstico, predicción y/o pronóstico de septicemia y usos del mismo
|
|
MX2011000655A
(es)
|
2008-07-18 |
2011-03-21 |
Oragenics Inc |
Composiciones para la deteccion y tratamiento de cancer colorrectal.
|
|
EP2169077A1
(en)
|
2008-09-19 |
2010-03-31 |
Vereniging voor christelijk hoger onderwijs, wetenschappelijk onderzoek en patiëntenzorg |
Methods and compositions for diagnosing an adenocarcinoma
|
|
US20100204299A1
(en)
|
2009-02-11 |
2010-08-12 |
Daniel Regnier |
C-cbl and antagonists thereof for the treatment and diagnosis of cancer
|
|
WO2010096154A2
(en)
*
|
2009-02-20 |
2010-08-26 |
Onconome, Inc. |
Compositions and methods for diagnosis and prognosis of colorectal cancer
|
|
JP5384672B2
(ja)
|
2009-02-24 |
2014-01-08 |
エフ．ホフマン−ラ ロシュ アーゲー |
癌のマーカーとしてのｓ−ＥｒｂＢ−３の使用
|
|
WO2011047358A1
(en)
|
2009-10-15 |
2011-04-21 |
Crescendo Bioscience |
Biomarkers and methods for measuring and monitoring inflammatory disease activity
|
|
US7736861B1
(en)
|
2009-10-19 |
2010-06-15 |
Aveo Pharmaceuticals, Inc. |
Tivozanib response prediction
|
|
EP2501845A4
(en)
*
|
2009-11-20 |
2013-04-24 |
Univ Louisville Res Found |
KREBSBIOMARKER
|
|
EP2553463B1
(en)
|
2010-03-26 |
2017-05-03 |
Hongzhi Zou |
Methods and materials for detecting colorectal neoplasm
|
|
US10119959B2
(en)
|
2010-06-25 |
2018-11-06 |
The Board Of Trustees Of The Leland Stanford Junior University |
Method of assaying an individual for immune impairment
|
|
GB201012590D0
(en)
|
2010-07-27 |
2010-09-08 |
Queen Mary & Westfield College |
Methods for diagnosing cancer
|
|
US8389684B2
(en)
|
2010-09-13 |
2013-03-05 |
Tsinghua University |
Tumor biomarker
|
|
WO2012101283A1
(en)
|
2011-01-28 |
2012-08-02 |
Biosystems International Sas |
Combinatorial biomarkers for clinical applications in lung cancer patient management
|
|
EP2678448A4
(en)
|
2011-02-22 |
2014-10-01 |
Caris Life Sciences Luxembourg Holdings S A R L |
CIRCULATING BIOMARKERS
|
|
WO2013028554A2
(en)
|
2011-08-19 |
2013-02-28 |
Myriad Genetics, Inc. |
Gene signatures for lung cancer prognosis and therapy selection
|
|
WO2013152989A2
(en)
|
2012-04-10 |
2013-10-17 |
Eth Zurich |
Biomarker assay and uses thereof for diagnosis, therapy selection, and prognosis of cancer
|
|
WO2013162368A1
(en)
|
2012-04-26 |
2013-10-31 |
Stichting Vu-Vumc |
Biomarkers
|
|
SG11201504241QA
(en)
|
2012-11-30 |
2015-06-29 |
Applied Proteomics Inc |
Method for evaluation of presence of or risk of colon tumors
|